Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 32076 - 32100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	SOD3	6649	upregulated	Cisplatin results in increased expression of SOD3 mRNA	4p15.2	A22205
Cisplatin	Approved Investigational	SON	6651	downregulated	Cisplatin results in decreased expression of SON mRNA	21q22.11	A20427
Cisplatin	Approved Investigational	SORL1	6653	downregulated	Cisplatin results in decreased expression of SORL1 mRNA	11q24.1	A20427
Cisplatin	Approved Investigational	SOWAHC	65124	downregulated	Cisplatin results in decreased expression of SOWAHC mRNA	2q13	A22204
Cisplatin	Approved Investigational	SP1	6667	upregulated	Cisplatin results in increased expression of SP1 mRNA	12q13.13	A22263 A21773
Cisplatin	Approved Investigational	SPP1	6696	downregulated	Cisplatin results in decreased expression of SPP1 mRNA	4q22.1	A22210
Cisplatin	Approved Investigational	SPRY1	10252	upregulated	Cisplatin results in increased expression of SPRY1 mRNA	4q28.1	A20427
Cisplatin	Approved Investigational	SPSB1	80176	upregulated	Cisplatin results in increased expression of SPSB1 mRNA	1p36.22	A20427
Cisplatin	Approved Investigational	SRBD1	55133	downregulated	Cisplatin results in decreased expression of SRBD1 mRNA	2p21	A22204
Cisplatin	Approved Investigational	SRD5A3	79644	downregulated	Cisplatin results in decreased expression of SRD5A3 mRNA	4q12	A20427
Cisplatin	Approved Investigational	SRGAP1	57522	downregulated	Cisplatin results in decreased expression of SRGAP1 mRNA	12q14.2	A22204 A22211
Cisplatin	Approved Investigational	SRGAP2	23380	downregulated	Cisplatin results in decreased expression of SRGAP2 mRNA	1q32.1	A22204
Cisplatin	Approved Investigational	SRXN1	140809	upregulated	Cisplatin results in increased expression of SRXN1 mRNA	20p13	A22204 A20427
Cisplatin	Approved Investigational	SS18L2	51188	upregulated	Cisplatin results in increased expression of SS18L2 mRNA	3p22.1	A22204
Cisplatin	Approved Investigational	ST7	7982	downregulated	Cisplatin results in decreased expression of ST7 mRNA	7q31.2	A22204
Cisplatin	Approved Investigational	STK39	27347	downregulated	Cisplatin results in decreased expression of STK39 mRNA	2q24.3	A22204
Cisplatin	Approved Investigational	STX8	9482	downregulated	Cisplatin results in decreased expression of STX8 mRNA	17p13.1	A22204
Cisplatin	Approved Investigational	SULF2	55959	downregulated	Cisplatin results in decreased expression of SULF2 mRNA	20q13.12	A20427
Cisplatin	Approved Investigational	SYT1	6857	downregulated	Cisplatin results in decreased expression of SYT1 mRNA	12q21.2	A22211
Cisplatin	Approved Investigational	SYTL1	84958	upregulated	Cisplatin results in increased expression of SYTL1 mRNA	1p36.11	A22203
Cisplatin	Approved Investigational	TALDO1	6888	upregulated	Cisplatin results in increased expression of TALDO1 mRNA	11p15.5	A20427
Cisplatin	Approved Investigational	TANC1	85461	downregulated	Cisplatin results in decreased expression of TANC1 mRNA	2q24.2	A22204
Cisplatin	Approved Investigational	TANC2	26115	downregulated	Cisplatin results in decreased expression of TANC2 mRNA	17q23.2-q23.3	A22204
Cisplatin	Approved Investigational	TAOK1	57551	upregulated	Cisplatin results in increased expression of TAOK1 mRNA	17q11.2	A20427
Cisplatin	Approved Investigational	TAP1	6890	upregulated	Cisplatin results in increased expression of TAP1 mRNA	6p21.32	A22204 A22202 A22212 A22203

Displaying entries 32076 - 32100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability